-
AstraZeneca set to make one of its first acquisitions in China
Gracell Biotechnologies would operate as wholly owned subsidiary under terms of deal
-
Who wants to be a modern CEO?
Bosses of publicly listed companies must keep a dizzying number of plates spinning
-
Ukraine destroys Russian landing ship in further blow to Black Sea fleet
Campaign against military sites in Crimea has been a rare bright spot for Kyiv in the war
-
Worrying about your festive BMI? You may not need to
The measure is saddled with scientific and historical baggage — and may not be that useful anyway
-
Russian opposition leader Navalny located in Arctic prison
Putin critic says he is ‘fine’ after supporters lost track of him for three weeks, raising fears about his safety
-
The art of superforecasting: how FT readers fared against the experts in 2023
The results of an informal contest offer insights into how to make your predictions for the next year more accurate
-
Fed rate pivot leaves stocks and bonds with ‘no room for error’
Market rally of the past two months has left markets vulnerable to disappointment, say big-name fund managers
-
European plans for battery supply chain face delays as US lures components producers
Materials manufacturer Novonix issues warning as region struggles to compete with US subsidies
0161 413 0666
